<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9825560</article-id>
    <article-id pub-id-type="pmid">36416273</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkac1075</article-id>
    <article-id pub-id-type="publisher-id">gkac1075</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>ClusterCAD 2.0: an updated computational platform for chimeric type I polyketide synthase and nonribosomal peptide synthetase design</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Tao</surname>
          <given-names>Xavier B</given-names>
        </name>
        <aff><institution>Department of Chemistry, University of California</institution>, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line> 94720, <country country="US">USA</country></aff>
        <aff><institution>Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory</institution>, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line> 94720, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>LaFrance</surname>
          <given-names>Sarah</given-names>
        </name>
        <aff><institution>Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory</institution>, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line> 94720, <country country="US">USA</country></aff>
        <aff><institution>Biofuels and Bioproducts Division, Joint BioEnergy Institute</institution>, <addr-line>5885 Hollis Street</addr-line>, <addr-line>Emeryville</addr-line>, <addr-line>CA</addr-line> 94608, <country country="US">USA</country></aff>
        <aff><institution>QB3 Institute, University of California</institution>, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line> 94720, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xing</surname>
          <given-names>Yifei</given-names>
        </name>
        <aff><institution>Department of Electrical Engineering and Computer Sciences, University of California</institution>, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line> 94720, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Nava</surname>
          <given-names>Alberto A</given-names>
        </name>
        <aff><institution>Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory</institution>, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line> 94720, <country country="US">USA</country></aff>
        <aff><institution>Department of Chemical and Biomolecular Engineering, University of California</institution>, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line> 94720, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Martin</surname>
          <given-names>Hector Garcia</given-names>
        </name>
        <aff><institution>Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory</institution>, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line> 94720, <country country="US">USA</country></aff>
        <aff><institution>Biofuels and Bioproducts Division, Joint BioEnergy Institute</institution>, <addr-line>5885 Hollis Street</addr-line>, <addr-line>Emeryville</addr-line>, <addr-line>CA</addr-line> 94608, <country country="US">USA</country></aff>
        <aff><institution>Department of Energy Agile BioFoundry</institution>, <addr-line>Emeryville</addr-line>, <addr-line>CA</addr-line> 94608, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Keasling</surname>
          <given-names>Jay D</given-names>
        </name>
        <aff><institution>Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory</institution>, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line> 94720, <country country="US">USA</country></aff>
        <aff><institution>Biofuels and Bioproducts Division, Joint BioEnergy Institute</institution>, <addr-line>5885 Hollis Street</addr-line>, <addr-line>Emeryville</addr-line>, <addr-line>CA</addr-line> 94608, <country country="US">USA</country></aff>
        <aff><institution>Department of Chemical and Biomolecular Engineering, University of California</institution>, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line> 94720, <country country="US">USA</country></aff>
        <aff><institution>Department of Bioengineering, University of California</institution>, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line> 94720, <country country="US">USA</country></aff>
        <aff><institution>QB3 Institute, University of California</institution>, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line> 94720, <country country="US">USA</country></aff>
        <aff><institution>Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark</institution> <addr-line>2800</addr-line><addr-line>Copenhagen</addr-line>, <country country="DK">Denmark</country></aff>
        <aff><institution>Center for Synthetic Biochemistry, Institute for Synthetic Biology, Shenzhen Institutes for Advanced Technologies</institution>, <addr-line>Shenzhen</addr-line>, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6056-353X</contrib-id>
        <name>
          <surname>Backman</surname>
          <given-names>Tyler W H</given-names>
        </name>
        <!--tbackman@lbl.gov-->
        <aff><institution>Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory</institution>, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line> 94720, <country country="US">USA</country></aff>
        <aff><institution>Biofuels and Bioproducts Division, Joint BioEnergy Institute</institution>, <addr-line>5885 Hollis Street</addr-line>, <addr-line>Emeryville</addr-line>, <addr-line>CA</addr-line> 94608, <country country="US">USA</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +1 510 486 7315; Email: <email>tbackman@lbl.gov</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>06</day>
      <month>1</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-11-23">
      <day>23</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>23</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <volume>51</volume>
    <issue>D1</issue>
    <fpage>D532</fpage>
    <lpage>D538</lpage>
    <history>
      <date date-type="accepted">
        <day>25</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>14</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="received">
        <day>15</day>
        <month>9</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkac1075.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Megasynthase enzymes such as type I modular polyketide synthases (PKSs) and nonribosomal peptide synthetases (NRPSs) play a central role in microbial chemical warfare because they can evolve rapidly by shuffling parts (catalytic domains) to produce novel chemicals. If we can understand the design rules to reshuffle these parts, PKSs and NRPSs will provide a systematic and modular way to synthesize millions of molecules including pharmaceuticals, biomaterials, and biofuels. However, PKS and NRPS engineering remains difficult due to a limited understanding of the determinants of PKS and NRPS fold and function. We developed ClusterCAD to streamline and simplify the process of designing and testing engineered PKS variants. Here, we present the highly improved ClusterCAD 2.0 release, available at <ext-link xlink:href="https://clustercad.jbei.org" ext-link-type="uri">https://clustercad.jbei.org</ext-link>. ClusterCAD 2.0 boasts support for PKS-NRPS hybrid and NRPS clusters in addition to PKS clusters; a vastly enlarged database of curated PKS, PKS-NRPS hybrid, and NRPS clusters; a diverse set of chemical ‘starters’ and loading modules; the new Domain Architecture Cluster Search Tool; and an offline Jupyter Notebook workspace, among other improvements. Together these features massively expand the chemical space that can be accessed by enzymes engineered with ClusterCAD.</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <caption>
            <p>New features in ClusterCAD 2.0 include support for Non-Ribosomal Peptide Synthetases (NRPSs), PKS-NRPS hybrids, a new Domain Architecture search tool, expanded PKS starters, and a Jupyter notebook system for programmatic access.</p>
          </caption>
          <graphic xlink:href="gkac1075figgra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>U.S. Department of Energy</institution>
            <institution-id institution-id-type="DOI">10.13039/100000015</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>EE0008926</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>DOE Joint BioEnergy Institute</institution>
          </institution-wrap>
        </funding-source>
        <award-id>DEAC02-05CH11231</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Philomathia Foundation</institution>
            <institution-id institution-id-type="DOI">10.13039/100019193</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="7"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Polyketide and nonribosomal peptide natural product derivatives are ubiquitous throughout clinical settings as antibiotics, antifungal, and immunosuppressants, among other applications. Initially inspired by the goal of developing novel drug analogs, polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS) engineering has since become a major focus within synthetic biology and has expanded to include the biological production of industrially-relevant commodity chemicals as well as small molecule unnatural products (<xref rid="B1" ref-type="bibr">1–11</xref>).</p>
    <p>With some exceptions, the sequence of domains and modules in Type I modular PKSs and NRPSs deterministically predict the structure of the produced polyketide or peptide. Both PKSs and NRPSs can include multiple polypeptide subunits, which in turn are constituted by modules. PKS modules are composed of at minimum a set of ketosynthase (KS), acyltransferase (AT), and acyl carrier protein (ACP) domains, but can also alter the functional groups present on the nascent polyketide using optional ketoreductase (KR), dehydratase (DH), enoyl reductase (ER), and methylation (MT) domains. KS domains catalyze a decarboxylative Claisen condensation of an AT-selected dicarboxylic acid extender with an acyl starter or intermediate. Reduction of the β-ketone may also occur in the presence of KR, DH, and ER domains to form a β-alcohol, <inline-formula><tex-math id="M0001" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\alpha$\end{document}</tex-math></inline-formula>,β-unsaturation, or a fully saturated β-methylene, respectively. Polyketides are then typically released from a PKS via a thioesterase (TE) domain, which catalyzes the hydrolysis of the ACP-polyketide thioester into a free carboxylic acid or cyclic lactone, or by a reductase (R) domain which releases the product as an aldehyde or alcohol. The polyketide may then undergo further tailoring reactions to form the final PKS product.</p>
    <p>NRPSs are very similarly organized, with modules at minimum composed of a set of condensation (C), adenylation (A), and peptidyl carrier protein (PCP) domains. C domains catalyze an amide condensation of an A-selected amino acid extender with an acyl starter or intermediate (<xref rid="B12" ref-type="bibr">12</xref>). Condensed peptides can be further modified utilizing optional epimerization (E), formylation (F), and <italic toggle="yes">N</italic>-methyltransferase (nMT) domains among others in order to change amino acid stereochemistry from L to D, add a <italic toggle="yes">N</italic>-formyl group to the N-terminal amino acid (<xref rid="B13" ref-type="bibr">13</xref>), or add a <italic toggle="yes">N</italic>-methyl group to the amide, respectively. Peptides are then also typically released from a NRPS via TE domains, catalyzing the hydrolysis of the PCP-peptide thioester into a free carboxylic acid, cyclic lactone, or cyclic lactam. The peptide may then undergo further tailoring reactions to form the final NRPS product.</p>
    <p>The deterministic, collinear, and modular nature of both PKS and NRPS clusters present valuable opportunities for combinatorial megasynthase engineering. In these clusters, the sequential organization of domains within modules and clusters directly determine the arrangement and composition of chemical intermediates produced. Furthermore, the modularity of megasynthase clusters render great flexibility for module rearrangements during engineering, generating a vast chemical space of feasible products utilizing combinatorial PKS and NRPS systems. Notable examples within this immense chemical space include petroleum-derived hydrocarbons, fatty acids, small molecule polyketide drugs, small molecule peptide/polypeptide drugs, some terpenes/terpenoids, and their derivatives or analogs.</p>
    <p>Many tools have been developed to assist with general retrobiosynthesis and metabolic engineering (<xref rid="B14" ref-type="bibr">14–18</xref>), but to our knowledge none have been developed to specifically assist PKS and/or NRPS engineering. ClusterCAD, however, informs PKS and NRPS engineering by providing a paradigm, database, and tools in which PKS and NRPS parts can be identified for combinatorial biosynthesis based on amino acid sequence similarity or target-intermediate substructure similarity tools, maximizing the chance of a functional engineered chimeric PKS or NRPS (<xref rid="B19" ref-type="bibr">19</xref>). ClusterCAD’s paradigm is also strongly bolstered by experimental evidence demonstrating strong correlation between product formation and atom-pair chemosimilarity (as determined by ClusterCAD’s structure search tool) between donor and recipient module substrates in PKS reductive loop swaps (<xref rid="B20" ref-type="bibr">20</xref>). ClusterCAD has also been used for providing structural insight into DH domain substrate selection via sequence analysis (<xref rid="B21" ref-type="bibr">21</xref>) and predicting AT substrates (<xref rid="B22" ref-type="bibr">22</xref>), among other applications. In this regard, ClusterCAD provides a flexible toolkit to inform the design and engineering of chimeric megasynthases (Figures <xref rid="F1" ref-type="fig">1</xref> and <xref rid="F2" ref-type="fig">2</xref>).</p>
    <fig position="float" id="F1">
      <label>Figure 1.</label>
      <caption>
        <p>Overview of ClusterCAD 2.0’s suite of features. Features new to ClusterCAD 2.0 (NRPSs, PKS-NRPS Hybrids, Domain Architecture Search, Offline Jupyter Notebook Workspace, and Celery Task Manager Queue) have been indicated in blue, while pre-existing features have been indicated in gray.</p>
      </caption>
      <graphic xlink:href="gkac1075fig1" position="float"/>
    </fig>
    <fig position="float" id="F2">
      <label>Figure 2.</label>
      <caption>
        <p>Sample PKS/NRPS megasynthase chimera engineering design workflow using ClusterCAD 2.0. First, a truncated PKS starting point is identified based on a desired target molecule using the structure search tool. Donor reductive/modification loops or domains are then identified by inspection of the cluster database, utilizing the sequence search tool and/or via the Domain Architecture Search Tool to inform modifications to the truncated PKS rendering it capable of generating the target molecule. The same tools can later be utilized to locate reductive/modification loops for domain swaps to optimize activity for increased target compound production.</p>
      </caption>
      <graphic xlink:href="gkac1075fig2" position="float"/>
    </fig>
  </sec>
  <sec sec-type="methods" id="SEC2">
    <title>NEW FEATURES AND METHODS</title>
    <sec id="SEC2-1">
      <title>NRPS support</title>
      <p>Previously in ClusterCAD, the only type of megasynthase available for chimeric design and engineering were PKS clusters consisting of KS, AT, KR, DH, ER, ACP, and TE domains. With ClusterCAD 2.0, NRPS clusters received support. This includes previously truncated PKS-NRPS hybrid clusters in addition to full NRPS clusters composed of condensation (C), adenylation (A), peptidyl carrier protein (PCP), heterocyclization (Cy), epimerization (E), formylation (F), N-methyltransferase (nMT), monooxygenase-interrupted adenylation (AOX), terminal reductase (R), and oxygenase-recruiting X (X) domains (Figure <xref rid="F3" ref-type="fig">3</xref>). Each domain simulates chemical reactions computationally using reaction SMARTS (<ext-link xlink:href="https://www.daylight.com/dayhtml/doc/theory/theory.smarts.html" ext-link-type="uri">https://www.daylight.com/dayhtml/doc/theory/theory.smarts.html</ext-link>) and the cluster loading pipeline was adapted to recognize these domains from annotations generated by antibiotics and Secondary Metabolite Analysis (antiSMASH) and configure them accordingly (<xref rid="B23" ref-type="bibr">23</xref>).</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>ClusterCAD entry for bacitracin, a newly added NRPS cluster. The ClusterCAD page for each cluster now contains new interface features including the Reviewed/Unreviewed Cluster indicator suggesting manual correction status, cluster notes providing relevant publications, and an option to toggle domain annotations for both AT and A domains.</p>
        </caption>
        <graphic xlink:href="gkac1075fig3" position="float"/>
      </fig>
      <p>A domains, especially following Cy domains, are frequently found to contain an oxidation or reduction domain looped out of itself used to catalyze the oxidation or reduction of thiazoline or oxazoline moieties into thiazols and oxazols or thiazolidines and oxazolidines, respectively. This catalytic activity was reflected by establishing A domain types as ‘oxidation’, ‘reduction,’ or ‘none’ if it performs neither additional reaction.</p>
      <p>Similarly, C domain types vary depending on the nature of the reaction they catalyze, and were annotated through the antiSMASH output. Some C domains that begin chain extension at the N-terminus were designated as the ‘Starter’ type, C domains catalyzing the condensation between L amino acids as the ‘LCL’ type, C domains catalyzing the condensation between a D and L amino acid as ‘DCL’, C domains performing condensations within a glycopeptide NRP cluster as ‘Glycopeptide’, and dual condensation/epimerization C domains both performing a condensation followed with epimerization of the amino acid as ‘Dual.’</p>
      <p>Through the addition of NRPS domains, 16 previously truncated or newly added PKS-NRPS hybrid clusters such as rapamycin (<xref rid="B24" ref-type="bibr">24</xref>), FK520 (<xref rid="B25" ref-type="bibr">25</xref>), and meridamycin (<xref rid="B26" ref-type="bibr">26</xref>) became fully supported.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Database expansion and updates</title>
      <p>ClusterCAD 2.0 provides users with a more expanded, comprehensive, and informative database. ClusterCAD 2.0’s database contains a total of 531 PKS, PKS-NRPS hybrid, and NRPS clusters, 183 of which have been manually curated based on experimental evidence from published literature—a ∼2.5-fold increase from ClusterCAD’s original 72 manually curated clusters.</p>
      <p>The database expansion also features improvements to assess the quality of selected PKS and NRPS components for PKS–NRPS engineering experiments. A new Reviewed/Unreviewed Cluster Indicator designates whether a cluster has been manually corrected with experimental evidence or has not yet been manually reviewed and is displaying default antiSMASH annotations. When browsing the list of clusters, users have the option to either browse reviewed clusters only or both reviewed and unreviewed clusters. Similarly, when utilizing ClusterCAD’s substructure search or sequence search tool, users may select whether they prefer to search either reviewed clusters only or both reviewed and unreviewed clusters. By including unreviewed clusters, but marking them as such, we enable users to access a much larger set of potential megasynthase parts for engineering than those that have been well studied and characterized.</p>
      <p>Furthermore, Cluster Notes now showcase any curation notes, annotations, references, or publications relevant to the cluster. Every cluster newly added in ClusterCAD 2.0 provides relevant publication(s) used for curating and annotating each cluster in addition to any curation notes for the user when considering the cluster or its components for engineering efforts. Cluster Notes are displayed at the top left of each cluster, and if available, will open a pop-up window with the aforementioned information.</p>
    </sec>
    <sec id="SEC2-3">
      <title>Improved database dependencies and pipeline</title>
      <p>ClusterCAD 2.0’s database utilizes cluster annotations generated using antiSMASH 6.0 and cluster information using MIBiG (Minimum Information about a Biosynthetic Gene Cluster) 2.0 (<xref rid="B27" ref-type="bibr">27</xref>). Updated multiple times since the original ClusterCAD’s usage of antiSMASH 3.0, antiSMASH 6.0 features improved NRPS adenylation domain substrate recognition, efficiency improvements, and module detection that power ClusterCAD 2.0’s improved ability to generate clusters based on the organization of detected modules or prediction of NRPS domain substrates (<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B28" ref-type="bibr">28</xref>).</p>
      <p>ClusterCAD 2.0 also boasts a powerful new pipeline tailored for generating clusters from antiSMASH 6.0’s annotations. In addition to support for updated dependencies, the new pipeline also accommodates the importation of more clusters. To reflect the diversity of PKS and NRPS clusters in nature (<xref rid="B29" ref-type="bibr">29</xref>), the new pipeline supports a multitude of new loading module configurations, including N-terminal ACPs as a standalone module, CoA ligase (CAL) based CAL-ACP, CAL-PCP, AT-ACP, and A-PCP domain organizations. Furthermore, the new pipeline also automates structure-informed adjustments to PKS reductive domain activities to reliably reflect the correct biosynthesis steps. Incomplete module annotations or natural cluster evolution will infrequently cause modules to contain reductive domains lacking other reductive domains critical for its prerequisite reaction. For example, the first module in the AbsB2 subunit of the Abyssomicin cluster contains a DH domain (as predicted by antiSMASH) but lacks the KR domain necessary to generate the subsequently dehydrated alcohol. In this case, the new pipeline recognizes the lack of a domain required for a prerequisite reaction and inactivates any subsequent reductive domains. This prevents reductive domains lacking a suitable precursor substrate from being annotated as active.</p>
      <p>These dependency updates and pipeline improvements provide users with higher quality and more numerous clusters (over 7× as many including unreviewed clusters).</p>
    </sec>
    <sec id="SEC2-4">
      <title>Expanded database structure diversity via newly supported cluster and domain features</title>
      <p>Several additional features pertinent to new substrate loading domains and chain-release mechanisms were added to ClusterCAD 2.0. Standalone N-terminal acyl carrier protein (ACP) domains are a structural feature frequently observed in many PKS and NRPS clusters, where the N-terminal ACP domain loads a structural intermediate generated from a series of preceding non-modular reactions. N-terminal ACP loading substrates vary by complexity and functional group composition between clusters, providing an extraordinary level of chemical diversity nonexistent with traditional PKS-NRPS starter or extender substrates.</p>
      <p>Additionally, polyketide chain-releasing thioesterase (TE) domains now support lactam ring formation. In most PKSs, TE domains found at the C-terminal end of polyketide assembly lines release the polyketide by catalyzing the formation of a free carboxylic acid via thioester hydrolysis or a lactone via cyclization. However, in some PKS clusters like cremimycin (<xref rid="B30" ref-type="bibr">30</xref>) and many NRPSs like bacitracin (<xref rid="B31" ref-type="bibr">31</xref>), the TE domain catalyzes the formation of a lactam via cyclization. This new functionality has rendered support for a multitude of clusters boasting cyclic lactams and cyclic peptides, both of which are chemical moieties frequently found in both natural products and industrially useful synthetic chemicals. These new chemical motifs and clusters featuring them provide many novel substrates and domains, presenting as attractive targets for PKS or NRPS engineering.</p>
      <p>Terminal reductase (R) domains are also newly supported. In an NADPH-dependent reaction, R domains can reduce the R-polyketide or R-peptide thioester linkage into an aldehyde or alcohol depending on the domain's target level of reduction. In clusters like Spumigin E and Coelimycin, peptide or polyketide chain release depends on R domain mediated reductive release, therefore providing additional clusters and unique functional groups that can be taken advantage of in PKS-NRPS engineering.</p>
      <p>Support for N-terminal ACP domains, TE domain lactam formation, and R domain terminal reductive release immensely enhances the chemical diversity of new structure possibilities within ClusterCAD 2.0. This expanded cluster and chemical library can be easily harnessed for PKS-NRPS engineering using the chemical structure search tool linked to ClusterCAD 2.0’s vastly expanded database or simply by browsing clusters.</p>
    </sec>
    <sec id="SEC2-5">
      <title>Domain Architecture Cluster Search tool</title>
      <p>Due to the deterministic nature of PKSs and NRPSs, finding specific domain arrangements within natural clusters is immensely useful as they provide valuable starting points and structural insight for PKS and NRPS engineering. In this regard, ClusterCAD 2.0 offers the Domain Architecture Cluster Search (e.g. Domain Search), a new tool enabling the querying of specific customized arrangements of PKS domains (NRPS support is under development). The tool allows users to assemble sequences of domains, specify domain attributes (e.g. AT substrates and KR stereochemistry), and submit the query to search the ClusterCAD database for matches. Matching or similar cluster hits are then displayed by similarity score for review. Reviewing cluster hits can yield insight into the ordering, sequences, and nascent chemical chain structures of natural clusters within the ClusterCAD database resembling the query cluster domain arrangement and attributes. Furthermore, the tool can be used to elucidate structural alterations (e.g. substrate domain or reductive loop swaps) necessary for engineering existing natural clusters into producing a modified target chemical structure. This tool works by converting the sequence of domains in a megasynthase enzyme into a sequence of Unicode text characters, each representing a unique chemical configuration of a domain (e.g. a ketoreductase or KR of Type A1). We then compare the query to enzymes in the database by computing the Levenshtein distance (<xref rid="B32" ref-type="bibr">32</xref>). The Levenshtein distance is a uniquely useful similarity metric for megasynthase engineering because it reports ‘distance’ as a real world number of domain changes (e.g. delete, replace, or add) required to convert one enzyme design into another, and provides a list of these modifications suitable for guiding the automated or manual design of chimeric enzymes. The Domain Architecture Cluster Search therefore serves as an invaluable tool for both discovering natural cluster starting points and providing structural insight for PKS and NRPS engineering.</p>
    </sec>
    <sec id="SEC2-6">
      <title>Offline Jupyter Notebook Workspace</title>
      <p>ClusterCAD 2.0 also offers an offline Jupyter Notebook workspace environment for software development useful for prototyping both standalone and ClusterCAD database-dependent programs. Support for an offline Jupyter Notebook workspace allows users to generate and run custom scripts and programs within ClusterCAD, extending the utility of ClusterCAD’s database beyond currently available tools and vastly increasing ClusterCAD’s potential for assisting PKS and NRPS engineering or other research applications. For instance, users might find it useful to extract libraries from the database with more complex rules beyond those possessed by preexisting ClusterCAD tools, especially if they are concerned with particular domains or domains possessing specific domain attributes (e.g. KR type). In this regard, the user could compose and run a script exporting sequences fulfilling specified conditions into a FASTA file. The offline Jupyter Notebook workspace therefore substantially increases database versatility by supporting a multitude of applications both within and beyond chimeric megasynthase engineering, ranging from using alignment dissimilarity predictions to inform domain swap experiments to generating megasynthase phylogenetic trees. Additionally, users can utilize the offline Jupyter Notebook workspace to manage and run any standalone Python scripts, Jupyter Notebooks, and programs.</p>
    </sec>
    <sec id="SEC2-7">
      <title>Celery task manager</title>
      <p>To improve the efficiency of running tool queries, ClusterCAD 2.0 features a Celery distributed task queue. The Celery task queue enables long running tool queries to run in the background, without timing out the users web connection. This provides the potential for much more complex queries, and lays a foundation for long running compute intensive analysis tools which we plan to add in the future.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="SEC3">
    <title>CONCLUSION</title>
    <p>To the best of our knowledge, ClusterCAD remains the only comprehensive web-based toolkit developed specifically to aid in chimeric megasynthase design. ClusterCAD 2.0’s improvements reinforce this mission through vast increases in cluster database size, expanded megasynthase diversity, additional powerful search tools, and informative interface features.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC4">
    <title>DATA AVAILABILITY</title>
    <p>ClusterCAD 2.0 can be freely accessed at: <ext-link xlink:href="https://clustercad.jbei.org/" ext-link-type="uri">https://clustercad.jbei.org/</ext-link>. The ClusterCAD source code is available at <ext-link xlink:href="https://github.com/JBEI/clusterCAD" ext-link-type="uri">https://github.com/JBEI/clusterCAD</ext-link>, released under a BSD style license. The source code also allowed users to run their own local/offline instance of ClusterCAD, including the integrated Jupyter Notebook Workspace.</p>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p>We wish to acknowledge OpenEye Scientific Software and ChemAxon for academic software licenses, as well as Mark Kulawik for computing support.</p>
  </ack>
  <sec id="SEC5">
    <title>FUNDING</title>
    <p>U.S. Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy (EERE), Bioenergy Technologies Office [EE0008926 to T.W.H.B., J.D.K., H.G.M.]; DOE Joint BioEnergy Institute (<ext-link xlink:href="http://www.jbei.org" ext-link-type="uri">http://www.jbei.org</ext-link>) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DEAC02-05CH11231 to J.D.K., H.G.M.]; Philomathia Foundation [to J.D.K.]. Funding for open access charge: Funding for open access charge: Joint BioEnergy Institute.</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. J.D.K. has financial interests in Amyris, Ansa Biotechnologies, Apertor Pharma, Berkeley Yeast, Cyklos Materials, Demetrix, Lygos, Napigen, ResVita Bio and Zero Acre Farms.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weissman</surname><given-names>K.J.</given-names></string-name>, <string-name><surname>Leadlay</surname><given-names>P.F.</given-names></string-name></person-group><article-title>Combinatorial biosynthesis of reduced polyketides</article-title>. <source>Nat. Rev. Microbiol.</source><year>2005</year>; <volume>3</volume>:<fpage>925</fpage>–<lpage>936</lpage>.<pub-id pub-id-type="pmid">16322741</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yuzawa</surname><given-names>S.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>K.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>G.</given-names></string-name>, <string-name><surname>Baidoo</surname><given-names>E.E.K.</given-names></string-name>, <string-name><surname>Northen</surname><given-names>T.R.</given-names></string-name>, <string-name><surname>Adams</surname><given-names>P.D.</given-names></string-name>, <string-name><surname>Katz</surname><given-names>L.</given-names></string-name>, <string-name><surname>Keasling</surname><given-names>J.D.</given-names></string-name></person-group><article-title>Comprehensive in vitro analysis of acyltransferase domain exchanges in modular polyketide synthases and its application for short-chain ketone production</article-title>. <source>ACS Synth. Biol.</source><year>2017</year>; <volume>6</volume>:<fpage>139</fpage>–<lpage>147</lpage>.<pub-id pub-id-type="pmid">27548700</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hagen</surname><given-names>A.</given-names></string-name>, <string-name><surname>Poust</surname><given-names>S.</given-names></string-name>, <string-name><surname>Rond</surname><given-names>T.de</given-names></string-name>, <string-name><surname>Fortman</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Katz</surname><given-names>L.</given-names></string-name>, <string-name><surname>Petzold</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Keasling</surname><given-names>J.D</given-names></string-name></person-group><article-title>Engineering a polyketide synthase for in vitro production of adipic acid</article-title>. <source>ACS Synth. Biol.</source><year>2016</year>; <volume>5</volume>:<fpage>21</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">26501439</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>H.-M.</given-names></string-name>, <string-name><surname>Stephan</surname><given-names>P.</given-names></string-name>, <string-name><surname>Kries</surname><given-names>H.</given-names></string-name></person-group><article-title>Engineering DNA-templated nonribosomal peptide synthesis</article-title>. <source>Cell Chem. Biol.</source><year>2021</year>; <volume>28</volume>:<fpage>221</fpage>–<lpage>227</lpage>.<pub-id pub-id-type="pmid">33238159</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cai</surname><given-names>W.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>W.</given-names></string-name></person-group><article-title>Engineering modular polyketide synthases for production of biofuels and industrial chemicals</article-title>. <source>Curr. Opin. Biotechnol.</source><year>2018</year>; <volume>50</volume>:<fpage>32</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">28946011</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pourmasoumi</surname><given-names>F.</given-names></string-name>, <string-name><surname>De</surname><given-names>S.</given-names></string-name>, <string-name><surname>Peng</surname><given-names>H.</given-names></string-name>, <string-name><surname>Trottmann</surname><given-names>F.</given-names></string-name>, <string-name><surname>Hertweck</surname><given-names>C.</given-names></string-name>, <string-name><surname>Kries</surname><given-names>H.</given-names></string-name></person-group><article-title>Proof-reading thioesterase boosts activity of engineered nonribosomal peptide synthetase</article-title>. <source>ACS Chem. Biol.</source><year>2022</year>; <volume>17</volume>:<fpage>2382</fpage>–<lpage>2388</lpage>.<pub-id pub-id-type="pmid">36044980</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cruz-Morales</surname><given-names>P.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>K.</given-names></string-name>, <string-name><surname>Landera</surname><given-names>A.</given-names></string-name>, <string-name><surname>Cort</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Young</surname><given-names>R.P.</given-names></string-name>, <string-name><surname>Kyle</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Bertrand</surname><given-names>R.</given-names></string-name>, <string-name><surname>Iavarone</surname><given-names>A.T.</given-names></string-name>, <string-name><surname>Acharya</surname><given-names>S.</given-names></string-name>, <string-name><surname>Cowan</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Biosynthesis of polycyclopropanated high energy biofuels</article-title>. <source>Joule</source>. <year>2022</year>; <volume>6</volume>:<fpage>1590</fpage>–<lpage>1605</lpage>.</mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>K.</given-names></string-name>, <string-name><surname>Zhong</surname><given-names>W.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Molnár</surname><given-names>I.</given-names></string-name></person-group><article-title>Engineering the biosynthesis of fungal nonribosomal peptides</article-title>. <source>Nat. Prod. Rep.</source><year>2022</year>; <pub-id pub-id-type="doi">10.1039/D2NP00036A</pub-id>.</mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Winn</surname><given-names>M.</given-names></string-name>, <string-name><surname>Fyans</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>Zhuo</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Micklefield</surname><given-names>J.</given-names></string-name></person-group><article-title>Recent advances in engineering nonribosomal peptide assembly lines</article-title>. <source>Nat. Prod. Rep.</source><year>2016</year>; <volume>33</volume>:<fpage>317</fpage>–<lpage>347</lpage>.<pub-id pub-id-type="pmid">26699732</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tietze</surname><given-names>A.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>Y.-N.</given-names></string-name>, <string-name><surname>Kronenwerth</surname><given-names>M.</given-names></string-name>, <string-name><surname>Bode</surname><given-names>H.B.</given-names></string-name></person-group><article-title>Nonribosomal peptides produced by minimal and engineered synthetases with terminal reductase domains</article-title>. <source>ChemBioChem</source>. <year>2020</year>; <volume>21</volume>:<fpage>2750</fpage>–<lpage>2754</lpage>.<pub-id pub-id-type="pmid">32378773</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Calcott</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Owen</surname><given-names>J.G.</given-names></string-name>, <string-name><surname>Ackerley</surname><given-names>D.F.</given-names></string-name></person-group><article-title>Efficient rational modification of non-ribosomal peptides by adenylation domain substitution</article-title>. <source>Nat. Commun.</source><year>2020</year>; <volume>11</volume>:<fpage>4554</fpage>.<pub-id pub-id-type="pmid">32917865</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Süssmuth</surname><given-names>R.D.</given-names></string-name>, <string-name><surname>Mainz</surname><given-names>A.</given-names></string-name></person-group><article-title>Nonribosomal peptide synthesis-principles and prospects</article-title>. <source>Angew. Chem. Int. Ed</source>. <year>2017</year>; <volume>56</volume>:<fpage>3770</fpage>–<lpage>3821</lpage>.</mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schoenafinger</surname><given-names>G.</given-names></string-name>, <string-name><surname>Schracke</surname><given-names>N.</given-names></string-name>, <string-name><surname>Linne</surname><given-names>U.</given-names></string-name>, <string-name><surname>Marahiel</surname><given-names>M.A.</given-names></string-name></person-group><article-title>Formylation domain: an essential modifying enzyme for the nonribosomal biosynthesis of linear gramicidin</article-title>. <source>J. Am. Chem. Soc.</source><year>2006</year>; <volume>128</volume>:<fpage>7406</fpage>–<lpage>7407</lpage>.<pub-id pub-id-type="pmid">16756271</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Song</surname><given-names>C.</given-names></string-name>, <string-name><surname>Luan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>R.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Hou</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Cui</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Cui</surname><given-names>T.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>L.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Tang</surname><given-names>Y.-J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>RedEx: a method for seamless DNA insertion and deletion in large multimodular polyketide synthase gene clusters</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>e130</fpage>.<pub-id pub-id-type="pmid">33119745</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Whitmore</surname><given-names>L.S.</given-names></string-name>, <string-name><surname>Nguyen</surname><given-names>B.</given-names></string-name>, <string-name><surname>Pinar</surname><given-names>A.</given-names></string-name>, <string-name><surname>George</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hudson</surname><given-names>C.M.</given-names></string-name></person-group><article-title>RetSynth: determining all optimal and sub-optimal synthetic pathways that facilitate synthesis of target compounds in chassis organisms</article-title>. <source>BMC Bioinf.</source><year>2019</year>; <volume>20</volume>:<fpage>461</fpage>.</mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Delépine</surname><given-names>B.</given-names></string-name>, <string-name><surname>Duigou</surname><given-names>T.</given-names></string-name>, <string-name><surname>Carbonell</surname><given-names>P.</given-names></string-name>, <string-name><surname>Faulon</surname><given-names>J.-L.</given-names></string-name></person-group><article-title>RetroPath2.0: a retrosynthesis workflow for metabolic engineers</article-title>. <source>Metab. Eng.</source><year>2018</year>; <volume>45</volume>:<fpage>158</fpage>–<lpage>170</lpage>.<pub-id pub-id-type="pmid">29233745</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Campodonico</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Andrews</surname><given-names>B.A.</given-names></string-name>, <string-name><surname>Asenjo</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Palsson</surname><given-names>B.O.</given-names></string-name>, <string-name><surname>Feist</surname><given-names>A.M.</given-names></string-name></person-group><article-title>Generation of an atlas for commodity chemical production in escherichia coli and a novel pathway prediction algorithm, GEM-Path</article-title>. <source>Metab. Eng.</source><year>2014</year>; <volume>25</volume>:<fpage>140</fpage>–<lpage>158</lpage>.<pub-id pub-id-type="pmid">25080239</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hatzimanikatis</surname><given-names>V.</given-names></string-name>, <string-name><surname>Li</surname><given-names>C.</given-names></string-name>, <string-name><surname>Ionita</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Henry</surname><given-names>C.S.</given-names></string-name>, <string-name><surname>Jankowski</surname><given-names>M.D.</given-names></string-name>, <string-name><surname>Broadbelt</surname><given-names>L.J.</given-names></string-name></person-group><article-title>Exploring the diversity of complex metabolic networks</article-title>. <source>Bioinformatics</source>. <year>2005</year>; <volume>21</volume>:<fpage>1603</fpage>–<lpage>1609</lpage>.<pub-id pub-id-type="pmid">15613400</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eng</surname><given-names>C.H.</given-names></string-name>, <string-name><surname>Backman</surname><given-names>T.W.H.</given-names></string-name>, <string-name><surname>Bailey</surname><given-names>C.B.</given-names></string-name>, <string-name><surname>Magnan</surname><given-names>C.</given-names></string-name>, <string-name><surname>García Martín</surname><given-names>H.</given-names></string-name>, <string-name><surname>Katz</surname><given-names>L.</given-names></string-name>, <string-name><surname>Baldi</surname><given-names>P.</given-names></string-name>, <string-name><surname>Keasling</surname><given-names>J.D.</given-names></string-name></person-group><article-title>ClusterCAD: a computational platform for type i modular polyketide synthase design</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>D509</fpage>–<lpage>D515</lpage>.<pub-id pub-id-type="pmid">29040649</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zargar</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lal</surname><given-names>R.</given-names></string-name>, <string-name><surname>Valencia</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Backman</surname><given-names>T.W.H.</given-names></string-name>, <string-name><surname>Cruz-Morales</surname><given-names>P.</given-names></string-name>, <string-name><surname>Kothari</surname><given-names>A.</given-names></string-name>, <string-name><surname>Werts</surname><given-names>M.</given-names></string-name>, <string-name><surname>Wong</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Bailey</surname><given-names>C.B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Chemoinformatic-Guided engineering of polyketide synthases</article-title>. <source>J. Am. Chem. Soc.</source><year>2020</year>; <volume>142</volume>:<fpage>9896</fpage>–<lpage>9901</lpage>.<pub-id pub-id-type="pmid">32412752</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barajas</surname><given-names>J.F.</given-names></string-name>, <string-name><surname>McAndrew</surname><given-names>R.P.</given-names></string-name>, <string-name><surname>Thompson</surname><given-names>M.G.</given-names></string-name>, <string-name><surname>Backman</surname><given-names>T.W.H.</given-names></string-name>, <string-name><surname>Pang</surname><given-names>B.</given-names></string-name>, <string-name><surname>de Rond</surname><given-names>T.</given-names></string-name>, <string-name><surname>Pereira</surname><given-names>J.H.</given-names></string-name>, <string-name><surname>Benites</surname><given-names>V.T.</given-names></string-name>, <string-name><surname>Martín</surname><given-names>H.G.</given-names></string-name>, <string-name><surname>Baidoo</surname><given-names>E.E.K.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Structural insights into dehydratase substrate selection for the borrelidin and fluvirucin polyketide synthases</article-title>. <source>J. Ind. Microbiol. Biotechnol.</source><year>2019</year>; <volume>46</volume>:<fpage>1225</fpage>–<lpage>1235</lpage>.<pub-id pub-id-type="pmid">31115703</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Romo</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Shiraishi</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ikeuchi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>G.-M.</given-names></string-name>, <string-name><surname>Geng</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>Y.-H.</given-names></string-name>, <string-name><surname>Liem</surname><given-names>P.H.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ogasawara</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Shin-Ya</surname><given-names>K.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The amipurimycin and miharamycin biosynthetic gene clusters: unraveling the origins of 2-Aminopurinyl peptidyl nucleoside antibiotics</article-title>. <source>J. Am. Chem. Soc.</source><year>2019</year>; <volume>141</volume>:<fpage>14152</fpage>–<lpage>14159</lpage>.<pub-id pub-id-type="pmid">31150226</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blin</surname><given-names>K.</given-names></string-name>, <string-name><surname>Shaw</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kloosterman</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Charlop-Powers</surname><given-names>Z.</given-names></string-name>, <string-name><surname>van Wezel</surname><given-names>G.P.</given-names></string-name>, <string-name><surname>Medema</surname><given-names>M.H.</given-names></string-name>, <string-name><surname>Weber</surname><given-names>T.</given-names></string-name></person-group><article-title>2021) antiSMASH 6.0: improving cluster detection and comparison capabilities</article-title>. <source>Nucleic Acids Res.</source><volume>49</volume>:<fpage>W29</fpage>–<lpage>W35</lpage>.<pub-id pub-id-type="pmid">33978755</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schwecke</surname><given-names>T.</given-names></string-name>, <string-name><surname>Aparicio</surname><given-names>J.F.</given-names></string-name>, <string-name><surname>Molnár</surname><given-names>I.</given-names></string-name>, <string-name><surname>König</surname><given-names>A.</given-names></string-name>, <string-name><surname>Khaw</surname><given-names>L.E.</given-names></string-name>, <string-name><surname>Haydock</surname><given-names>S.F.</given-names></string-name>, <string-name><surname>Oliynyk</surname><given-names>M.</given-names></string-name>, <string-name><surname>Caffrey</surname><given-names>P.</given-names></string-name>, <string-name><surname>Cortés</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lester</surname><given-names>J.B.</given-names></string-name></person-group><article-title>The biosynthetic gene cluster for the polyketide immunosuppressant rapamycin</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>1995</year>; <volume>92</volume>:<fpage>7839</fpage>–<lpage>7843</lpage>.<pub-id pub-id-type="pmid">7644502</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>K.</given-names></string-name>, <string-name><surname>Chung</surname><given-names>L.</given-names></string-name>, <string-name><surname>Revill</surname><given-names>W.P.</given-names></string-name>, <string-name><surname>Katz</surname><given-names>L.</given-names></string-name>, <string-name><surname>Reeves</surname><given-names>C.D.</given-names></string-name></person-group><article-title>The FK520 gene cluster of streptomyces hygroscopicus var. ascomyceticus (ATCC 14891) contains genes for biosynthesis of unusual polyketide extender units</article-title>. <source>Gene</source>. <year>2000</year>; <volume>251</volume>:<fpage>81</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">10863099</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>He</surname><given-names>M.</given-names></string-name>, <string-name><surname>Haltli</surname><given-names>B.</given-names></string-name>, <string-name><surname>Summers</surname><given-names>M.</given-names></string-name>, <string-name><surname>Feng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Hucul</surname><given-names>J.</given-names></string-name></person-group><article-title>Isolation and characterization of meridamycin biosynthetic gene cluster from streptomyces sp. NRRL 30748</article-title>. <source>Gene</source>. <year>2006</year>; <volume>377</volume>:<fpage>109</fpage>–<lpage>118</lpage>.<pub-id pub-id-type="pmid">16806745</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kautsar</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Blin</surname><given-names>K.</given-names></string-name>, <string-name><surname>Shaw</surname><given-names>S.</given-names></string-name>, <string-name><surname>Navarro-Muñoz</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Terlouw</surname><given-names>B.R.</given-names></string-name>, <string-name><surname>van der Hooft</surname><given-names>J.J.J.</given-names></string-name>, <string-name><surname>van Santen</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Tracanna</surname><given-names>V.</given-names></string-name>, <string-name><surname>Suarez Duran</surname><given-names>H.G.</given-names></string-name>, <string-name><surname>Pascal Andreu</surname><given-names>V.</given-names></string-name><etal>et al</etal>.</person-group><article-title>MIBiG 2.0: a repository for biosynthetic gene clusters of known function</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D454</fpage>–<lpage>D458</lpage>.<pub-id pub-id-type="pmid">31612915</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blin</surname><given-names>K.</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>T.</given-names></string-name>, <string-name><surname>Chevrette</surname><given-names>M.G.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Schwalen</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Kautsar</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Suarez Duran</surname><given-names>H.G.</given-names></string-name>, <string-name><surname>de Los Santos</surname><given-names>E.L.C.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>H.U.</given-names></string-name>, <string-name><surname>Nave</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>antiSMASH 4.0-improvements in chemistry prediction and gene cluster boundary identification</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>W36</fpage>–<lpage>W41</lpage>.<pub-id pub-id-type="pmid">28460038</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Keatinge-Clay</surname><given-names>A.T.</given-names></string-name></person-group><article-title>The uncommon enzymology of cis-acyltransferase assembly lines</article-title>. <source>Chem. Rev.</source><year>2017</year>; <volume>117</volume>:<fpage>5334</fpage>–<lpage>5366</lpage>.<pub-id pub-id-type="pmid">28394118</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Amagai</surname><given-names>K.</given-names></string-name>, <string-name><surname>Takaku</surname><given-names>R.</given-names></string-name>, <string-name><surname>Kudo</surname><given-names>F.</given-names></string-name>, <string-name><surname>Eguchi</surname><given-names>T.</given-names></string-name></person-group><article-title>A unique amino transfer mechanism for constructing the β-amino fatty acid starter unit in the biosynthesis of the macrolactam antibiotic cremimycin</article-title>. <source>ChemBioChem</source>. <year>2013</year>; <volume>14</volume>:<fpage>1998</fpage>–<lpage>2006</lpage>.<pub-id pub-id-type="pmid">24014395</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Konz</surname><given-names>D.</given-names></string-name>, <string-name><surname>Klens</surname><given-names>A.</given-names></string-name>, <string-name><surname>Schörgendorfer</surname><given-names>K.</given-names></string-name>, <string-name><surname>Marahiel</surname><given-names>M.A.</given-names></string-name></person-group><article-title>The bacitracin biosynthesis operon of bacillus licheniformis ATCC 10716: molecular characterization of three multi-modular peptide synthetases</article-title>. <source>Chem. Biol.</source><year>1997</year>; <volume>4</volume>:<fpage>927</fpage>–<lpage>937</lpage>.<pub-id pub-id-type="pmid">9427658</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Levenshtein</surname><given-names>V.I.</given-names></string-name></person-group><article-title>Binary codes capable of correcting deletions, insertions and reversals</article-title>. <source>Sov. Phys. Dokl.</source><year>1966</year>; <volume>10</volume>:<fpage>707</fpage>–<lpage>710</lpage>.</mixed-citation>
    </ref>
  </ref-list>
</back>
